During the past decade, Genesee Surgical Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genesee Surgical Associates" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Genesee Surgical Associates" are "Breast Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Genesee Surgical Associates" in a lesser frequency.

Most popular intervention types in "Genesee Surgical Associates" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Raloxifene" (1 trials), "Tamoxifen" (1 trials), "conventional surgery" (1 trials) and "laparoscopic surgery" (1 trials). Other intervention names were less common.

The vast majority of trials in "Genesee Surgical Associates" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Genesee Surgical Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Genesee Surgical Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Genesee Surgical Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".